Back
Genmab AS Vs. DocuSign Industry Stock Comparison
Sell
49
GMAB
Genmab AS
Last Price:
$20.53
Seasonality Move:
10.21%
Buy
82
DOCU
DocuSign
Last Price:
$85.72
Seasonality Move:
15.31%
Sell
49
Genmab AS (GMAB)
is a Sell
Is Genmab AS a Buy, Sell or Hold?
-
GMAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DOCU Stock Price Chart
GMAB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 42.2 | Sell |
Chaikin Money Flow: | -702268 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.9 - 23.22) | Sell |
Bollinger Bands (100): | (20.16 - 22.68) | Sell |
DOCU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.64 | Sell |
Relative Strength Index (14 RSI): | 53.41 | Buy |
Chaikin Money Flow: | 3107309 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (79.97 - 89.85) | Buy |
Bollinger Bands (100): | (76.52 - 94.14) | Buy |
GMAB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.03 | Sell |
20-day SMA: | 22.17 | Sell |
50-day SMA: | 21.2 | Sell |
200-day SMA: | 23.92 | Sell |
8-day EMA: | 21.39 | Sell |
20-day EMA: | 21.68 | Sell |
50-day EMA: | 21.48 | Sell |
200-day EMA: | 23.83 | Sell |
DOCU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 80.51 | Buy |
20-day SMA: | 83.13 | Buy |
50-day SMA: | 88.51 | Sell |
200-day SMA: | 70.82 | Buy |
8-day EMA: | 80.97 | Buy |
20-day EMA: | 83.26 | Buy |
50-day EMA: | 85.79 | Sell |
200-day EMA: | 75.3 | Buy |
Genmab AS Earnings Growth & GMAB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $5.18 per share, an increase this year of $0.19 per share, and an increase next year of $0.40 per share.
DocuSign Earnings Growth & DOCU Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.00 per share, an increase this year of $0.66 per share, and a decrease next year of $0.04 per share.
Genmab AS Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
DocuSign Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |